Valuetainment - May 22, 2026


"You'll Regain All The Weight" - Health Expert's Ozempic WARNING To Charles Barkley & Oprah

Topics
Hosted by
Mentioned
"Your Doctor Is FAILING You" - The Truth About Why Men's Testosterone Is COLLAPSING "Don't Pretend It'll Solve The Problem" - Jeff Bezos DISMANTLES Mamdani's Tax The Rich Agenda

Episode Stats


Length

19 minutes

Words per minute

186.23

Word count

3,587

Sentence count

220

Harmful content

Misogyny

2

sentences flagged

Toxicity

1

sentences flagged

Hate speech

4

sentences flagged


Summary

Summaries generated with gmurro/bart-large-finetuned-filtered-spotify-podcast-summ .

Why do we get so fat in America? Is it because of GLP-1s? Or is there something else going on with our food supply that we just don t know about? Today, we talk to Rob and Humberto about this and more.

Transcript

Transcript generated with Whisper (turbo).
Misogyny classifications generated with MilaNLProc/bert-base-uncased-ear-misogyny .
Toxicity classifications generated with s-nlp/roberta_toxicity_classifier .
Hate speech classifications generated with facebook/roberta-hate-speech-dynabench-r4-target .
Topics generated with Qwen2.5-3B-Instruct.
Hosts, guests, and mentioned names generated with spaCy (en_core_web_sm), reconciled against Wikidata.
00:00:00 Rosen lasagna, medium power, 15 minutes.
00:00:04 Sounds like Ojo time.
00:00:06 Let's play.
00:00:07 Feel the fun with Play Ojo, the online casino with all the latest slot and live casino games.
00:00:12 What you win is yours to keep with no wagering requirements, instant payouts, and no minimum withdrawals.
00:00:18 Hey, I just won.
00:00:19 Woo-hoo!
00:00:20 Feel the fun, Play Ojo. 0.73
00:00:22 Honey, forget about the lasagna.
00:00:24 Let's celebrate.
00:00:25 19 plus Ontario only.
00:00:25 Please play responsibly.
00:00:26 Concerned about your gambling or that of someone close to you?
00:00:27 Call 1-866-531-2600 or visit connexontario.ca.
00:00:30 The other day I'm watching a, I was watching either a playoff game or something,
00:00:34 and then I saw Barkley come up, and Barkley was doing a GLP-1 commercial.
00:00:39 I'm like, Charles Barkley, I've seen the Serena Williams one for only $10 or whatever,
00:00:44 so it's more of a money ad that she does, and she's lost a lot of weight.
00:00:48 But then I saw Barkley, and I saw the numbers reported that Barkley had lost,
00:00:53 he went from 360 pounds to weighing 252 pounds to 267.
00:01:03 He's lost 85 pounds using this product on Mount Jaro,
00:01:09 which is like a form of a GLP-1, okay?
00:01:13 And he says, I know GLP-1s are effective.
00:01:15 I witnessed it myself.
00:01:17 The difficult part was obtaining medication.
00:01:19 He wants to get back to his playing days,
00:01:21 which, by the way, he looks great.
00:01:22 He's 258, he's 267 pounds today.
00:01:25 Playing days was 250.
00:01:27 And then I had Humberto and Rob pull up some stats on obesity and being overweight.
00:01:32 And I saw the video you posted of New York back in 1920 versus today.
00:01:36 Rob, I don't know if you have that clip or not.
00:01:38 And this is such a great video of comparing what America looked like in 1920.
00:01:44 Well, it's overlapping because he's speaking on it.
00:01:46 So if you can find another one, Rob will show it.
00:01:48 It's just 1920.
00:01:49 You type in on X, New York 1920 versus today.
00:01:52 And the numbers we pulled up is in 1920, only 3% of Americans were obese.
00:02:00 Today, it's 41%.
00:02:02 Why do we get so fat in America?
00:02:06 It's over 70% obese and overweight, Pat.
00:02:09 Over 70% obese and overweight.
00:02:11 And that's according to CDC, by the way, that number you're giving.
00:02:13 That's according to CDC.
00:02:15 And so this is crazy.
00:02:17 And it's so interesting because I think that more than anything,
00:02:19 the GLP-1 conversation.
00:02:22 Manjaro is a dual agonist,
00:02:25 so it's GLP-1 and GIP.
00:02:26 It's also called terzepatide.
00:02:28 These medications work,
00:02:30 but the fact that they work so well,
00:02:32 I think is a clarion call to this idea
00:02:35 that like, how did we get so fat?
00:02:37 This question you're asking.
00:02:38 They partially ameliorate a problem
00:02:40 that did not exist 100 years ago.
00:02:42 You look at New York, we were not fat.
00:02:45 And so I think that this is a clear indication
00:02:48 that our food supply has just become so badly tainted and oprah's talked about this she had a
00:02:53 very viral clip on the view i think it was from 2024 or 2025 where she said i have the fat gene
00:03:01 which is not true there's no such thing as a fat gene but what there is is something called food
00:03:05 noise this idea and i think oprah poor oprah didn't realize this she used to promote weight
00:03:10 watchers right so she was promoting low quality food in low calorie packets when we are eating 0.99
00:03:17 this tainted food that is full of all these ingredients that no one can pronounce.
00:03:21 You, your great-grandmother, my great-grandmother wouldn't recognize these food ingredients.
00:03:25 These food ingredients are literally poisoning our brains, the satiety centers in the hypothalamus
00:03:31 of our brains, and we cannot stop eating.
00:03:34 And so in some ways, these GLP-1s, Monjaro, Ozempic, and Retatrutide, which is a triple
00:03:39 agonist, they sort of address this food noise, the poisoning of our brains by the food, but
00:03:45 there are things to think about here. There are potential downsides to these medications also.
00:03:50 But for me, the biggest thing this conversation around Ozempic, Manjaro, and Reditrutide says is
00:03:55 how did we get so poisoned by our food? If we need a medication to actually calm the food noise,
00:04:02 to partially reverse the complete destruction of our satiety that these engineered foods have
00:04:10 caused, can't we just talk about going back to simple foods? Because in the early 1900s,
00:04:15 Most of what we ate were single-ingredient foods.
00:04:19 We talked about this on the last podcast.
00:04:21 What are single-ingredient foods?
00:04:23 Beef, chicken, fish, pork, lettuce, apples, celery.
00:04:29 Cheese, milk.
00:04:30 These are single-ingredient foods.
00:04:32 It is virtually impossible to get fat or stay fat eating those foods.
00:04:39 Even if you overeat.
00:04:41 It's very difficult to overeat those foods
00:04:43 because our body has a programmed satiety mechanism in our brain
00:04:47 that is hundreds of thousands of years old.
00:04:50 It's very difficult to overeat steak and boiled potatoes.
00:04:54 It's very difficult to overeat steak and lettuce.
00:04:57 It's very difficult to overeat chicken and avocado.
00:05:00 You will get a very clear satiety signal, and you're just not interested in eating.
00:05:05 So, Dan, let me ask you this question.
00:05:06 I read a book called Ageless Man, and I don't know if you've heard of this book,
00:05:11 Ageless Man, where it talks about in the book that men with lower testosterone is worse for
00:05:21 their health than higher testosterone. And they did a test on rats, I don't know, mouse,
00:05:27 certain testing they did, giving them testosterone and seeing how they would, and they would live 0.97
00:05:32 longer, ageless men. So the argument then becomes, you're better off being on TRT than not being on 0.96
00:05:37 TRT okay there's a benefit to it some people are not sitting there saying okay Charles Barkley
00:05:43 he's been dealing with weight for a while is he healthier continuing to live his lifestyle
00:05:49 doesn't change anything he stays at 352 doesn't use GLP-1 or is he better off using GLP-1 drop
00:05:55 into 267 he's carrying 85 pounds less fat what's a better decision for a guy like Barkley it's
00:06:02 almost certainly using the GLP-1 so in this case it's a good case to use it it's a good case to
00:06:06 Use it provided that Charles won't change his diet, right?
00:06:09 And we can talk about the long-term consequences of using that GLP-1, potentially.
00:06:14 But yeah, there is a use case for these medications, unquestionably.
00:06:18 In some ways, like I said, they probably reverse or help address the poisoning of our brains that's been going on by our food system.
00:06:26 The first choice that I would have for Charles is, can we just get you a chef to cook you delicious food that's singling?
00:06:33 He can afford that.
00:06:33 Yeah, to get you single ingredient foods all the time.
00:06:36 Because that, I believe, is going to lead to better long-term weight loss.
00:06:41 One of the first issues I have with these GLPs is you're probably on them for life.
00:06:45 So if Charles stops the GLP-1, the research is pretty clear that he's going to regain the weight within one to two years.
00:06:53 Almost all of it and sometimes more.
00:06:56 Why is that?
00:06:57 Because when you use the GLP-1s, there are changes that happen in the body that don't catch up to the changes that you're making with food.
00:07:05 So when you're using a GLP-1, it creates satiety.
00:07:08 There are some potentially beneficial metabolic effects of these medications.
00:07:12 But when you stop it, you're going to go back to eating the food you were eating before because you haven't made lifestyle changes.
00:07:17 You haven't developed discipline.
00:07:18 You haven't understood how to make the right food choices.
00:07:21 And your eating habits are going to outpace your metabolism because these GLPs will slow down your metabolism because you're eating less food.
00:07:30 And so you've lost fat.
00:07:32 You've also lost muscle mass.
00:07:33 muscle mass is positive for our metabolism. Muscle mass burns calories when we're sitting
00:07:38 here having a podcast. That's what you want. And so if you're on a GLP-1, you have to be very
00:07:42 careful you don't lose too much muscle mass by continuing to exercise, continuing to eat enough
00:07:46 protein. But when you stop it, the eating habits that you never fixed will outpace the metabolism
00:07:53 that's been changed by the GLPs. There's a study that came out saying that when you stop a GLP-1,
00:07:57 you regain the weight four times faster than if you stopped exercise. Four times faster. So this
00:08:03 is the problem. And so it's great for the pharmaceutical companies. I think that they
00:08:08 say Manjaro terzepatide is the number one selling drug in the world now. And I think people are
00:08:14 suggesting that retitrutide, which is the triple agonist, it's not FDA cleared yet, but probably
00:08:18 will obtain FDA clearance in 2027, will be the best selling drug in the world almost immediately.
00:08:25 And so here we are with very widely used drugs that people may need to be on for life to maintain the, quote, benefits.
00:08:36 That's a little concerning because people run into GI side effects.
00:08:39 People can run into other side effects, ocular side effects.
00:08:43 And then what do you do if you cannot continue?
00:08:45 The discontinuation rate of these drugs is not insignificant because people do run into side effects.
00:08:51 So is it a short-term fix?
00:08:53 Potentially.
00:08:53 Does it have side effects?
00:08:55 guess it's they're fairly safe drugs on balance they're not perfect they're fairly safe but you
00:09:00 are i want people to understand that when you take these drugs you are essentially committing
00:09:06 yourself to a lifelong use of the drug which is always a little bit concerning for us right
00:09:10 and there is another way which is like we said humans have eaten single ingredient foods or
00:09:17 foods that your great grandmother would recognize the label for hundreds of thousands of years
00:09:21 Try getting fat on chicken breast and avocado.
00:09:25 It doesn't happen.
00:09:26 Regular food.
00:09:26 But that's boring, right?
00:09:27 That's slow.
00:09:28 Come on, Paul.
00:09:30 I don't have the time for that.
00:09:31 I would much rather take the shortcut.
00:09:33 10 million people, according to JPMorgan Chase, are using GLP-1's 2025.
00:09:38 They're guesstimating it's going to be $25 million by 2030, four years from now.
00:09:43 And then on top of that, the cost is what?
00:09:46 $1,200 a month, they say, give or take.
00:09:48 If you have insurance, of course, it's a different story.
00:09:51 but $1,200. So the average person to do $1,200 a month, and you'll need to be on it for, you know,
00:09:57 depending, let's just say it's a year program, that's $15,000. That's a big cost to a lot of
00:10:02 different people. So some of these insurance companies are now adding it to it. So then the
00:10:06 question becomes, what is it? Is it really, when I talk to people who use it, all it does is it
00:10:12 tells you you're not hungry. Is that really all it does? It does a few more things in that. It does.
00:10:16 it's a diabetes drug. It's not like it was... It's also a diabetes drug. They're also using
00:10:21 it for addictions. It's being studied for addictions, which is a very interesting
00:10:25 sort of sidebar. Because the GLP-1 receptors do occur in the pleasure pathways in the brain. So
00:10:32 there's a lot of complex names here. VTA, ventral tegmental area, nucleus accumbens.
00:10:37 These are the pleasure pathways in our brain that are activated with nicotine, with alcohol,
00:10:41 with romance, sex, learning. And so I think that the next use we'll see for these medications is
00:10:48 with addictions. But then there's another sort of corollary conversation. And this is perhaps
00:10:54 not the most important part of the GLP-1 conversation, but it is relevant for some
00:11:00 people that is it possible that if you use these medications, it will affect your ability to make
00:11:06 new relationships fall in love and desire and this is at this point it's purely anecdotal but
00:11:11 the conversations on x are very compelling what does that mean what does that have to do with
00:11:15 relationships well because if you're if you're over stimulating so glp1 agonist if you're
00:11:20 over stimulating the glp1 receptors in the pleasure pathways in the brain the vta the
00:11:26 nucleus accumbens are you blunting your ability just like they're going to be effective for
00:11:31 addictions they sort of decrease the food reward and they're going to decrease the reward of
00:11:36 alcohol they decrease the reward of smoking and potentially other addictive drugs are they going
00:11:40 to decrease the normal pleasure pathways that are activated when you fall in love with someone
00:11:45 when you have desire this is a concern again i don't think this is the primary conversation
00:11:50 but this is the corollary conversation of maybe it's not a good thing to be on these for the rest
00:11:55 of our lives and we don't know i want to be very clear we don't know the answer to this
00:11:59 but if you look at it 2005 right if i'm not mistaken yeah glp1's uh first one that was
00:12:04 FDA approved was sold in 2005. So we only have 20 years of data on this. That's for Ozempic,
00:12:11 for semaglutide, and Manjaro is very more recent, and retitrutide has never been approved by the
00:12:16 FDA. So we don't even have long-term data on retitrutide. Is it on track to get? It is. It
00:12:20 is. 2027, yes. So for someone like Charles Barkley, great example, probably on balance,
00:12:25 these are positive if he can't make lifestyle changes. But what about the millions of young
00:12:32 men who are at 15% body fat and could just eat single ingredient foods, but are going to take
00:12:38 retitrutide or terzepatide to get down to 11% to look shredded. Is it going to affect relationships?
00:12:45 Is it going to affect how we relate to people? It's a really compelling question because the
00:12:49 neurobiological mechanisms in our brain are there. And if you look on X, there are a lot of these
00:12:53 threads. People are saying, I was at a conversation. I just saw it last night. You can pull it up on X.
00:12:58 I don't know the account. I think it's Tyler Durden's account. It's this guy.
00:13:01 This is an eponymous account from Fight Club.
00:13:06 And he was just saying, I was at dinner the other day and people were saying that they're falling out of love on Ozempic.
00:13:13 And it was like over a million impressions or something.
00:13:16 It was really interesting that when you put that out there, people are actually saying, this happened to me.
00:13:21 Now, again, there are lots of cases where—
00:13:23 Can you pull that up?
00:13:23 I'm actually curious to know the comment section on what they said, if you find that.
00:13:27 Was that recently?
00:13:27 I just saw it last night, so it's got to be pretty recent on his account.
00:13:30 We can find it.
00:13:32 I would say, yeah, search for Tyler Durden, like falling out of love, GLP-1s or something. 0.99
00:13:37 Yeah. 1.00
00:13:39 But keep going.
00:13:39 Yeah.
00:13:40 I'm tracking.
00:13:40 So falling out of love.
00:13:42 And there's been a lot of theorizing around this just because of these neurobiological preserved pathways in the brain.
00:13:50 So who knows here, right?
00:13:51 Who knows?
00:13:51 But I think that my point with Ozempic, Monjaro, Terzepatide is there is another way, right?
00:13:58 And I wish I could have told this to Oprah 15, 20 years ago.
00:14:01 There is another way to do this, and it goes back to something that's not sexy,
00:14:06 that's a little bit easier, that requires discipline, but that works longer term,
00:14:09 which is, hey, simple, single-ingredient foods, this is the way.
00:14:15 Yes.
00:14:16 Hearing some interesting stories from friends who have friends taking peptides,
00:14:20 falling completely out of love overnight with wives and partners.
00:14:23 Go a little bit lower.
00:14:24 You're not permitted to comment this post if you took failed the COVID IQ test,
00:14:29 the rule of 5.5 billion shears go lower let's see if people are saying at this stem keep going lower
00:14:34 yeah that's interesting to be to be thinking about that kills enjoyment and and by peptides he's
00:14:39 talking about glp1s here because those are the peptides that are affecting the enjoyment in
00:14:44 the ventral tegmental area the nucleus accumbens and it's something we don't we don't know for
00:14:49 sure but it's it's very concerning could it be that it's because you know every time there's
00:14:53 something there's fear porn could it be the fact that you're on glp ones if you're 350 pounds
00:15:00 and you don't make a lot of money and you're not that successful odds are your wife is probably 0.90
00:15:05 close to 350 pound type of a person i don't know if i'm being a prick here i'm just saying
00:15:10 statistically unless if you're charles barkley you're famous you're going to get any girl you
00:15:14 want for the most part but odds are you're not dating somebody as attractive as you so then all
00:15:19 of a sudden you get on GLP once in Ozembeck and you lose 50, 60, 70 pounds. I'll let you say you
00:15:24 were 220. Now you're at 150. You look amazing. People are now looking at you. Maybe it's not
00:15:29 that you're falling out of love with your spouse. Maybe you now have options you didn't have before.
00:15:34 It's very possible. And there are, there certainly are situations where both people in the relationship
00:15:41 get on these medications. Both people become more attractive and probably the relationship gets
00:15:45 better but i just think it's a really interesting biological mechanism in the brain with no
00:15:52 neurological pathways and you can look it up too these medications do have effects for addiction
00:15:56 so there's something going on oh no question pleasure no question about that there's no
00:16:00 there's no biological free lunch pat and that's that's just a little note of caution that i want
00:16:05 to add to these a little asterisk i want to add to these medications no biological free lunch when
00:16:10 people are saying retitrutide is the best thing since sliced bread i'm thinking just wait just
00:16:14 wait you know because we're there's there's no biological free line yeah well we'll see we'll
00:16:19 see that part on what's going to happen the reality of it is uh in u.s i think the ozempic
00:16:24 product by itself plus the diabetes combined together is a 40 to an 80 billion dollar industry
00:16:30 right now and they're saying it's going to get to 100 to 200 billion dollars by 2030 2035
00:16:35 so when you see a number like that this brings me up to the next question
00:16:40 Last year, Big Pharma spent some $7 billion on advertising.
00:16:45 And one of the conversations you and I had, as well as I had with Bobby, was with Maha.
00:16:50 And when he would get in, there you go, $7 billion in 2025 Big Pharma.
00:16:55 That's a lot of money.
00:16:56 So that money is going to media, you know, channels, CNN, everybody's, Fox, NBC.
00:17:03 They're all getting a part of that money.
00:17:05 But one of the things we discussed was there's only two countries in the world that allow this.
00:17:09 It's us in New Zealand that, you know, Maha would possibly work on eliminating big pharma from being able to advertise on TV.
00:17:18 How much progress have you guys made on that?
00:17:20 I don't think there's been much progress on that, unfortunately.
00:17:22 Why do you think that is?
00:17:23 Well, you talked about it before, because if you eliminate the pharmaceutical ad revenue from television stations, you're going to see all the television stations collapse.
00:17:31 We can look up the amount of money spent by, we're looking at it right now,
00:17:34 but how much of any television station, any news channel is pharmaceutical ads?
00:17:42 It's a lot today.
00:17:43 I started off with the first story being Barclay because I saw it on an ad.
00:17:45 Yeah.
00:17:46 So if I don't see that on ad, I don't know if I know that Barclay lost weight.
00:17:51 What does it say, Rob?
00:17:54 13.1% of all national linear TV ad spends were from Big Pharma in Q3.
00:17:59 14 percent pharma spending grew to 16 percent by 2025 yeah well that's yeah it's a big it's a big
00:18:06 deal a lot of ads what's the likelihood that they'll get it done or this is something that's
00:18:12 probably not going to get done i don't see it happening okay it's just it's too close to home
00:18:16 you know it's too close to home i can't see it the lobby is too strong and again i would love to see
00:18:22 it happen a lot of people watch television a lot of people are influenced by these ads i don't see
00:18:28 it happening unfortunately okay hey guys i am paul saladino you can find me on minect if you have
00:18:32 any questions about diet health recovering from chronic illness or autoimmune disease i'm excited
00:18:37 to connect with you guys all there and i'll see you in there if you enjoy this video you want to
00:18:41 watch more videos like this click here and if you want to watch the entire podcast click here
00:18:46 the madame homes bike for brain health supporting baycrest returns on may 31st for its fifth
00:18:55 anniversary with a new start and finish at the Aga Khan Museum. Join thousands of cyclists as
00:19:00 we take over the DVP and Gardner Expressway in support of dementia research and brain health.
00:19:05 Riders of all abilities are welcome, and both regular bikes and e-bikes can participate.
00:19:09 Bring your friends, family, or corporate team and make an impact. Register today at bikeforbrainhealth.ca.